Using first-void urine for HPV testing in cervical cancer screening

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of using first-void urine samples as an alternative to traditional cervical sampling for HPV testing in cervical cancer screening. The research aims to address the low screening rates in France, where invasive cervical sampling is a significant barrier. By implementing a standardized urine collection protocol, the study seeks to determine the sensitivity of HPV PCR tests on urine samples and assess the acceptability of this method through participant questionnaires.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Female
* Age between 30 and 65
* Consulting in the Gynecology-Obstetrics department for primary cervical cancer screening
* Patient affiliated or entitled to a social security regimen
* Patient who has received information about the study and expressed non-opposition

Exclusion Criteria:

\-

Where it's running

• Service de Gynécologie Obstétrique - CHU Saint-Etienne
  Saint-Etienne, France Recruiting

Study contacts

• Principal investigator: Louise MONIOD, MD — Centre Hospitalier Universitaire de Saint Etienne
• Study coordinator: Louise MONIOD, MD
• Email: louise.moniod@chu-st-etienne.fr
• Phone: (0)4 77 82 83 83

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Blood ctDNA testing to guide follow-up and treatment for HPV-related cervical and anal canal cancers.

  This study will test whether regular blood tests for HPV ctDNA can guide follow-up and whether giving pembrolizumab after radiotherapy helps people with HPV-related cervical or anal canal cancer who still have positive ctDNA.

  Recruiting Phase 2 Instituto do Cancer do Estado de São Paulo · São Paulo · NCT06640283

• Finding HPV DNA in the blood of people with anal or cervical cancer.

  This study will test whether a blood test can find HPV DNA in people with HPV-related anal or cervical cancer before, during, and after radiation treatment.

  Recruiting at 2 sites University of Chicago · Chicago, Illinois and 1 other locations · NCT04857528

• Single Port Robotic System for Pediatric Surgery

  This study tests whether the Single Port robotic system can be safely used to perform certain pediatric abdominal surgeries (like pyeloplasty and reflux procedures) in children aged 1 to 17.

  Recruiting Centre Hospitalier Universitaire de Saint Etienne · Saint-Etienne · NCT07660497

• Sensory neuronopathy: finding the best disease scales for tracking progression

  This study tests which clinical scales best measure disease severity and progression in adults with sensory neuronopathy.

  Recruiting Centre Hospitalier Universitaire de Saint Etienne · Angers and 18 other locations · NCT07651540

• Multimodal approach to reduce urinary incontinence in young female athletes

  A multimodal program combining pelvic health education and core stability training is tested to see if it reduces urinary incontinence in young nulliparous female athletes.

  Recruiting Centre Hospitalier Universitaire de Saint Etienne · Saint-Etienne · NCT07644273

• Remediation of memory impairments using motor encoding and dynamic imagery in Alzheimer’s disease

  This trial tests whether combining real action, motor imagery, and dynamic video cues can help memory in people with early Alzheimer’s disease and compares it to a control group without Alzheimer’s.

  Recruiting Centre Hospitalier Universitaire de Saint Etienne · Grenoble and 2 other locations · NCT07632755

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.